Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in Serum IGF-1 Levels With Resistance Exercises in Patients With Knee Osteoarthritis and Their Association With Clinical and Radiological Parameters

NCT07890155 is registered in ClinicalTrials.gov with Sisli Hamidiye Etfal Training and Research Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07890155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in Serum IGF-1 Levels With Resistance Exercises in Patients With Knee Osteoarthritis and Their Association With Clinical and Radiological Parameters
Lead sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2026
Completion date
January 31, 2027
Enrollment
86 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome (mets), osteoarthritis (knee)

Arms

As registered; 2 arms.

  • Metabolic Phenotype Group ExperimentalResistance Exercise Program

    Patients with knee osteoarthritis who meet the criteria for metabolic syndrome (metabolic phenotype). This group will undergo an 8-week supervised resistance exercise program.

  • Non-Metabolic Phenotype Group ExperimentalResistance Exercise Program

    Patients with knee osteoarthritis who do not meet the criteria for metabolic syndrome. This group will also undergo the exact same 8-week supervised resistance exercise program.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Serum Insulin-like Growth Factor 1 (IGF-1) Levels Baseline and at 8 weeks

    Serum IGF-1 levels will be measured from fasting venous blood samples to evaluate the systemic anabolic response to the resistance exercise program.

Papers

PubMed papers this trial cites; 3 papers, results papers first, then newest first.

Source: PubMed, NCBI/NLM (public domain).

Lead sponsor's other trials

Sisli Hamidiye Etfal Training and Research Hospital, most recent start first.

Similar trials

Same condition (Metabolic Syndrome) and phase, most recent start first.